(Q24235460)

English

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease

scientific article (publication date: 12 May 2010)

In more languages

default for all languages

No label defined

No description defined

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease (English)

0 references

main subject

chronic obstructive pulmonary disease

0 references

author

Phillippa Poole

series ordinal

3

0 references

author name string

Emma J Welsh

series ordinal

1

0 references

Christopher J Cates

series ordinal

2

0 references

publication date

12 May 2010

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

Tiotropium for stable chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

Self-management education for patients with chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

Pulmonary rehabilitation for chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

Methodological issues in therapeutic trials of COPD.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

Methodologic shortcomings of the INSPIRE randomized trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

21 January 2018

Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Triple therapy for chronic obstructive pulmonary disease: trials catching up with clinical practice?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Premature discontinuation of patients: a potential bias in COPD clinical trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD007891.PUB2

0 references

Fatcat ID

release_hh5ifnynybgdje4bfpaaenwu2a

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/hh5ifnynybgdje4bfpaaenwu2a

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

20464758

0 references

(Q24235460)

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)